Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
Trial ID or NCT#
This is an open-label study to assess the safety, tolerability, efficacy and pharmacokinetics of eteplirsen in patients with early stage Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToShirley Paulose
Go Back To The Trial